Intestinal flora of healthy infants
Conditions
Interventions
Group with breastfeeding:Breastfeeding
Group of formula feeding with OPO structure lipids and probiotics:Feeding with formula with OPO structure lipids and probiotics
Group of formula feeding without OPO structure lipids and probiotics:Feeding with formula without OPO structure lipids and probiotics
Sponsors
Zhejiang University School of Medicine Children's Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 0.3 Years
Inclusion criteria
Inclusion criteria: (1) Healthy full-term infants (gestational aged >= 37 weeks, < 42 weeks) with a birth weight of 2.5~4kg were born 1 month after birth. (2) infants who have been exclusively breastfed or formula-fed within the past 72 hours; (3) no congenital abnormalities/birth defects, no genetic metabolic diseases or chromosomal diseases; (4) no family history of metabolic diseases; (5) no history of infectious diseases; (6) the infant's legal guardian agrees to participate in this clinical trial and signs a written informed consent.
Exclusion criteria
Exclusion criteria: (1) Infants with known history of severe allergies of both parents or one parent; (2) patients with diseases or high-risk factors that affect the growth and development of infants, such as 5-minute Apgar score 2 weeks during the neonatal period; (3) complicated with other heart and lung, digestive, nervous, kidney, blood system and other serious primary diseases or birth defects; (4) participated in other clinical trials within 1 month. (5) the investigator considers it inappropriate to participate in the clinical trial.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| length;weight; | — |
Countries
China
Contacts
Public ContactShao Jie
Zhejiang University School of Medicine Children's Hospital
Outcome results
None listed